These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27098685)

  • 1. α-Synuclein Mutation Inhibits Endocytosis at Mammalian Central Nerve Terminals.
    Xu J; Wu XS; Sheng J; Zhang Z; Yue HY; Sun L; Sgobio C; Lin X; Peng S; Jin Y; Gan L; Cai H; Wu LG
    J Neurosci; 2016 Apr; 36(16):4408-14. PubMed ID: 27098685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-Type Monomeric α-Synuclein Can Impair Vesicle Endocytosis and Synaptic Fidelity via Tubulin Polymerization at the Calyx of Held.
    Eguchi K; Taoufiq Z; Thorn-Seshold O; Trauner D; Hasegawa M; Takahashi T
    J Neurosci; 2017 Jun; 37(25):6043-6052. PubMed ID: 28576942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
    Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
    J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate.
    Schechter M; Atias M; Abd Elhadi S; Davidi D; Gitler D; Sharon R
    J Biol Chem; 2020 Dec; 295(52):18076-18090. PubMed ID: 33087443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor inhibits calcium channel activation, exocytosis, and endocytosis at a central nerve terminal.
    Baydyuk M; Wu XS; He L; Wu LG
    J Neurosci; 2015 Mar; 35(11):4676-82. PubMed ID: 25788684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
    Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword.
    Tan LY; Tang KH; Lim LYY; Ong JX; Park H; Jung S
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression.
    Song DY; Yuan L; Cui N; Feng C; Meng L; Wang XH; Xiang M; Liu D; Wang C; Zhang Z; Li JY; Li W
    J Neurochem; 2023 Nov; 167(3):461-484. PubMed ID: 37788328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis.
    Larsen KE; Schmitz Y; Troyer MD; Mosharov E; Dietrich P; Quazi AZ; Savalle M; Nemani V; Chaudhry FA; Edwards RH; Stefanis L; Sulzer D
    J Neurosci; 2006 Nov; 26(46):11915-22. PubMed ID: 17108165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.
    Martin LJ; Pan Y; Price AC; Sterling W; Copeland NG; Jenkins NA; Price DL; Lee MK
    J Neurosci; 2006 Jan; 26(1):41-50. PubMed ID: 16399671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.
    Gao HM; Kotzbauer PT; Uryu K; Leight S; Trojanowski JQ; Lee VM
    J Neurosci; 2008 Jul; 28(30):7687-98. PubMed ID: 18650345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
    Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
    Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein Pathology and Reduced Neurogenesis in the Olfactory System Affect Olfaction in a Mouse Model of Parkinson's Disease.
    Martin-Lopez E; Vidyadhara DJ; Liberia T; Meller SJ; Harmon LE; Hsu RM; Spence N; Brennan B; Han K; Yücel B; Chandra SS; Greer CA
    J Neurosci; 2023 Feb; 43(6):1051-1071. PubMed ID: 36596700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.
    Paumier KL; Sukoff Rizzo SJ; Berger Z; Chen Y; Gonzales C; Kaftan E; Li L; Lotarski S; Monaghan M; Shen W; Stolyar P; Vasilyev D; Zaleska M; D Hirst W; Dunlop J
    PLoS One; 2013; 8(8):e70274. PubMed ID: 23936403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
    Wislet-Gendebien S; Visanji NP; Whitehead SN; Marsilio D; Hou W; Figeys D; Fraser PE; Bennett SA; Tandon A
    BMC Neurosci; 2008 Sep; 9():92. PubMed ID: 18808659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
    Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
    J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.